4
Changes in Ownership
Bolt Biotherapeutics, Inc. Filed Acc 0000950170-24-026997
Options or other derivatives
- Chief Executive Officer acquired 654,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Schatzman Randall C Chief Executive Officer | 2024-03-04 | Grant or award · Stock Option (Right to Buy) | +654,000 | 235,000 | D | ||
Loading xslF345X05/ownership.xml…